Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Dobutamine-induced Intraventricular Obstruction
Fritock, Maria D., Manento, Megan N., Segura, Leal G., Segura, Leal G.

Anesthesiology | July 24, 2014 | Volume: 122 | Issue: 6 | Pages: 1414-1414

10.1097/aln.0000000000000387 | PMID 25057844 Get It

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
Mansour, Ahmad M. , Arévalo, J. Fernando , Kahtani, Eman Al, Zegarra, Hernando, Abboud, Emad B. , Anand, Rajiv, Ahmadieh, Hamid , Mirza, Salman, Tuncer, Samuray , Návea, Amparo , Mataix, J. , Ascaso, Francisco J., Pulido, José S. , Guthoff, Rainer , Goebel, Winfried, Banker, Alay , Gentile, Ronald C., Martinez, Isabel Alonso, Morris, Rodney J, Panday, Neeraj, Min, Park Jung, Mercé, Emilie, Lai, Timothy Y. Y. , Massoud, Vicky, Ghazi, Nicola G. , Abboud, Emad , Sisk, Robert A. , Roh, Young‐Jung , Martínez, Isabel Alonso, Massoud, Vicky A., Arevalo, Jose Fernando

Journal of Ophthalmology | July 23, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-8

10.1155/2014/210458 | PMID 25147732 Get It

We treated 26 eyes of 25 young patients having a mean age of 30 years with intravitreal vascular endothelial growth factor (VEGF) inhibitor for choroidal new vessel (CNV) formation overlying choroidal osteoma over a mean follow-up of 26 months. Mean number of injections was 2.4 at 6 months, 3.2 at 12 months, and 5.5 at 24 months. CNV was subfoveal in 14 eyes, juxtafoveal in 5, extrafoveal in 5, and peripapillary in 2. By paired comparison, mean decrease from baseline was 119.7 microns at 6 months (n=15;P=0.001), 105.3 microns at 1 year (n=10;P=0.03), and 157.6 microns at 2 years (n=7;P=0.08). BCVA improved by 3.3 lines at 6 months after therapy (n=26;P<0.001), 2.8 lines (n=20;P=0.01) at 1 year, and 3.1 lines (n=13;P=0.049) at 2 years. We conclude that intravitreal anti-VEGF injections improve vision in majority of eyes with CNV from choroidal osteoma.
Disparities in Imaging Utilization for Acute Ischemic Stroke Based on Patient Insurance Status
Brinjikji, Waleed , El‐Sayed, Abdulrahman M. , Cloft, Harry J. , Rabinstein, Alejandro A. , McDonald, Jennifer S.

American Journal of Roentgenology | July 23, 2014 | Volume: 203 | Issue: 2 | Pages: 372-376

10.2214/ajr.13.12008 | PMID 25055273 Get It

Defining the Optimal Cardiac Troponin T Threshold for Predicting Death Caused by Periprocedural Myocardial Infarction After Percutaneous Coronary Intervention
Herrmann, Joerg , Lennon, Ryan J. , Jaffe, Allan S. , Holmes, David R. , Rihal, Charanjit S. , Prasad, Abhiram , Jaffe, Allan S. , Rihal, Charanjit S. , Prasad, Abhiram

Circulation: Cardiovascular Interventions | July 23, 2014 | Volume: 7 | Issue: 4 | Pages: 533-542

10.1161/circinterventions.113.000544 | PMID 25052010 Get It

Background— There is controversy about the diagnostic and prognostic significance of percutaneous coronary intervention–related myocardial infarction, especially with the use of cardiac troponin T (cTnT). This analysis was designed to address the question of the presence and the level of a prognostic cTnT threshold. Methods and Results— We evaluated 5268 consecutive patients who underwent nonemergent percutaneous coronary intervention between 2000 and 2009 with a preprocedural cTnT level below the upper limit of normal (ULN, ≤0.01 ng/mL). Postprocedural cTnT and creatine kinase-MB mass levels (ULN, 6.7 ng/mL in men and 3.8 ng/mL in women) were found to be associated with 3-month mortality in Cox proportional hazard models (hazard ratio per doubling of cTnT, 1.24; 95% confidence interval, 1.08–1.43; P =0.003 and hazard ratio per doubling of creatine kinase-MB, 1.30; 95% confidence interval, 1.05–1.60; P =0.018), adjusted for the Mayo Clinic risk scores for in-hospital and postdischarge mortality. The optimal prognostic threshold for 3-month mortality was 25× ULN for cTnT (hazard ratio, 4.53; 99% confidence interval, 1.59–12.9; P <0.001), which provided similar information as a value of 5× ULN for creatine kinase-MB (hazard ratio, 4.31; 99% confidence interval, 1.27–14.6; P =0.002). The cumulative mortality rate was 0.6% at 91 days. Conclusions— A significant association of postpercutaneous coronary intervention cardiac biomarker elevation with a small number of postpercutaneous coronary intervention outcomes was noted for the early (first 91 days) follow-up period with an identifiable optimal threshold of 25× ULN (0.25, ng/mL) for cTnT, which provided similar early outcome information as a cutoff of 5× ULN for creatine kinase-MB.
Deleted in Breast Cancer 1 Limits Adipose Tissue Fat Accumulation and Plays a Key Role in the Development of Metabolic Syndrome Phenotype
Escande, Carlos , Nin, Verónica , Pirtskhalava, Tamar , Chini, Claudia C.S. , Tchkonia, Tamar , Kirkland, James L. , Chini, Eduardo N. , Tchkonia, T

Diabetes | July 23, 2014 | Volume: 64 | Issue: 1 | Pages: 12-22

10.2337/db14-0192 | PMID 25053585 Get It

Obesity is often regarded as the primary cause of metabolic syndrome. However, many lines of evidence suggest that obesity may develop as a protective mechanism against tissue damage during caloric surplus and that it is only when the maximum fat accumulation capacity is reached and fatty acid spillover occurs into to peripheral tissues that metabolic diseases develop. In this regard, identifying the molecular mechanisms that modulate adipocyte fat accumulation and fatty acid spillover is imperative. Here we identify the deleted in breast cancer 1 (DBC1) protein as a key regulator of fat storage capacity of adipocytes. We found that knockout (KO) of DBC1 facilitated fat cell differentiation and lipid accumulation and increased fat storage capacity of adipocytes in vitro and in vivo. This effect resulted in a “healthy obesity” phenotype. DBC1 KO mice fed a high-fat diet, although obese, remained insulin sensitive, had lower free fatty acid in plasma, were protected against atherosclerosis and liver steatosis, and lived longer. We propose that DBC1 is part of the molecular machinery that regulates fat storage capacity in adipocytes and participates in the “turn-off” switch that limits adipocyte fat accumulation and leads to fat spillover into peripheral tissues, leading to the deleterious effects of caloric surplus.
Implementation of Shared Decision Making in Cardiovascular Care
Coylewright, Megan , Frosch, Dominick L. , Shah, Nilay D. , Hess, Erik P.

Circulation: Cardiovascular Quality and Outcomes | July 23, 2014 | Volume: 7 | Issue: 5 | Pages: 797-803

10.1161/circoutcomes.113.000351 | PMID 25052074 Get It

Spillover of Cytokines and Reactive Oxygen Species in Ventilator-Induced Lung Injury Associated With Inflammation and Apoptosis in Distal Organs
Liu, Yung-Yang , Chiang, Chi-Huei, Chuang, Chiao–Hui, Liu, Shiou-Ling, Jheng, Yi‐Han, Ryu, Jay H. , Chiang, Chi‐Huei, Ryu, Jay H

Respiratory Care | July 23, 2014 | Volume: 59 | Issue: 9 | Pages: 1422-1432

10.4187/respcare.02992 | PMID 25053831 Get It

BACKGROUND: The mechanism between ventilator-induced lung injury (VILI) and multiple organ injury is unclear. The aim of our study was to investigate the mechanisms of VILI-induced distal organ injury. METHODS: VILI was induced in rat lungs with high tidal volume (V T ) ventilation of 40 mL/kg for 6 h. Rats with low V T ventilation of 6 mL/kg served as controls. Inflammatory and apoptotic indices in lung and distal organs were assessed. RESULTS: VILI increased lung weight, airway pressure, inflammation, and apoptotic pathologic changes without hemodynamic changes. The white blood cell count and the levels of H 2 O 2 , interleukin-1β (IL-1β), tumor necrosis factor alpha, and macrophage inflammatory protein-2 in bronchoalveolar lavage fluid were higher in the VILI group compared with the control group. H 2 O 2 , IL-1β, and tumor necrosis factor alpha in blood from the left ventricle were up-regulated. H 2 O 2 , IL-1β, tumor necrosis factor alpha, macrophage inflammatory protein-2, c-Jun N-terminal kinase, p38, nuclear factor kappa B, and caspase-3 in lung, heart, liver, and kidney tissues in the VILI group were up-regulated. Furthermore, the apoptotic score for the kidneys was higher than those for other distal organs in the VILI group. CONCLUSIONS: High V T ventilation induces VILI and is associated with inflammation and apoptosis in distal organs. Up-regulation of reactive oxygen species and cytokines in VILI is associated with systemic inflammatory responses. Kidney tissue appears to be more vulnerable than heart and liver tissues following VILI.
Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality
Xu, Hua , Aldrich, Melinda C. , Peterson, Neeraja B. , Levy, Mia , Shah, Anushi, Han, Xue, Ruan, Xiaoyang , Jiang, Min , Li, Ying , Julien, Jamii St., Friedman, Carol, Roden, Dan M. , Denny, Joshua C. , Chen, Qingxia , Liu, Hongfang , Dai, Qi , Han, Xue, Warner, Jeremy L. , Roden, Dan M. , Denny, Joshua C

Journal of the American Medical Informatics Association | July 23, 2014 | Volume: 22 | Issue: 1 | Pages: 179-191

10.1136/amiajnl-2014-002649 | PMID 25053577 Get It

Abstract Objectives Drug repurposing, which finds new indications for existing drugs, has received great attention recently. The goal of our work is to assess the feasibility of using electronic health records (EHRs) and automated informatics methods to efficiently validate a recent drug repurposing association of metformin with reduced cancer mortality. Methods By linking two large EHRs from Vanderbilt University Medical Center and Mayo Clinic to their tumor registries, we constructed a cohort including 32 415 adults with a cancer diagnosis at Vanderbilt and 79 258 cancer patients at Mayo from 1995 to 2010. Using automated informatics methods, we further identified type 2 diabetes patients within the cancer cohort and determined their drug exposure information, as well as other covariates such as smoking status. We then estimated HRs for all-cause mortality and their associated 95% CIs using stratified Cox proportional hazard models. HRs were estimated according to metformin exposure, adjusted for age at diagnosis, sex, race, body mass index, tobacco use, insulin use, cancer type, and non-cancer Charlson comorbidity index. Results Among all Vanderbilt cancer patients, metformin was associated with a 22% decrease in overall mortality compared to other oral hypoglycemic medications (HR 0.78; 95% CI 0.69 to 0.88) and with a 39% decrease compared to type 2 diabetes patients on insulin only (HR 0.61; 95% CI 0.50 to 0.73). Diabetic patients on metformin also had a 23% improved survival compared with non-diabetic patients (HR 0.77; 95% CI 0.71 to 0.85). These associations were replicated using the Mayo Clinic EHR data. Many site-specific cancers including breast, colorectal, lung, and prostate demonstrated reduced mortality with metformin use in at least one EHR. Conclusions EHR data suggested that the use of metformin was associated with decreased mortality after a cancer diagnosis compared with diabetic and non-diabetic cancer patients not on metformin, indicating its potential as a chemotherapeutic regimen. This study serves as a model for robust and inexpensive validation studies for drug repurposing signals using EHR data.
Evaluation and Treatment of Scaphoid Nonunions
Rhee, Peter C. , Jones, David, Shin, Alexander Y. , Bishop, Allen T.

JBJS Reviews | July 23, 2014 | Volume: 2 | Issue: 7 | Pages: No page available

10.2106/jbjs.rvw.m.00074 | PMID 27490062 Get It

Still Looking for Best PEEP
Hubmayr, Rolf D., Malhotra, Atul

Anesthesiology | July 22, 2014 | Volume: 121 | Issue: 3 | Pages: 445-446

10.1097/aln.0000000000000374 | PMID 25050574 Get It